1. Home
  2. USLM vs RCUS Comparison

USLM vs RCUS Comparison

Compare USLM & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USLM

United States Lime & Minerals Inc.

HOLD

Current Price

$109.84

Market Cap

3.1B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$25.38

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USLM
RCUS
Founded
1948
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Other Metals and Minerals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
2.8B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
USLM
RCUS
Price
$109.84
$25.38
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$138.00
$31.90
AVG Volume (30 Days)
119.9K
1.3M
Earning Date
04-29-2026
05-05-2026
Dividend Yield
0.19%
N/A
EPS Growth
23.22
N/A
EPS
1.06
N/A
Revenue
$144,435,000.00
$247,000,000.00
Revenue This Year
$27.25
N/A
Revenue Next Year
$13.76
$45.62
P/E Ratio
$103.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$94.41
$7.92
52 Week High
$141.44
$28.72

Technical Indicators

Market Signals
Indicator
USLM
RCUS
Relative Strength Index (RSI) 34.79 56.18
Support Level $107.82 $19.78
Resistance Level $129.37 $28.72
Average True Range (ATR) 6.32 1.76
MACD -2.53 -0.04
Stochastic Oscillator 19.27 61.39

Price Performance

Historical Comparison
USLM
RCUS

About USLM United States Lime & Minerals Inc.

United States Lime & Minerals Inc is engaged in the business of manufacturing lime and limestone products including PLS, quicklime, hydrated lime and lime slurry. It supplies its products predominantly to the construction (including highway, road, and building contractors), industrial (including paper and glass manufacturers), environmental (including municipal sanitation and water treatment facilities and flue gas treatment processes), metals (including steel producers), oil and gas services, roof shingle manufacturers and agriculture (including poultry and cattle feed producers) industries. The company operates through its Lime and Limestone Operations segment.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: